Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-28 01:39:38 - browse：86547

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

WSS

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

No plane should take off without an EpiPen onboard

Adults seen as increasingly susceptible to measles

Colonoscopy prep: Liquid

Orchard's therapy for neuron disease in children wins FDA approval

Future doctors should be trained to promote social change

entertainment

Wikipedia

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Sage hopes for a blockbuster in antidepressant now before FDA

Peter Hotez and the public health issue of online harassment

Neuroscience’s long legacy of racism

New air purifier tech could be key to improving indoor air quality

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Duchenne breakthrough therapy leaves behind pioneering families

Pence says 'crackpot lawyers' told Trump what he wanted to hear

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

hotspot

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Wildfire pollution widens asthma inequities on Long Island

The high personal cost of affirmative action for Black doctors

Trump indictment: Who are the 'co

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Asbestos, a deadly carcinogen, banned by EPA

knowledge

Wikipedia

hotspot

focus